Device / Technology News

RSS

BARDA awards Rapid Micro Biosystems $6.7M contract to develop rapid sterility testing platform for vaccines

Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, today announced that it has signed a contract with the Biomedical Advanced Research and Development Authority (BARDA) for the development of rapid sterility testing for vaccines as part of the Innovative Platform Technologies program of BARDA's Strategic Science and Technology Division.

23 Sep 2010

AstraZeneca to use THEW database for cardiac safety evaluation

AstraZeneca purchased a one-year membership to gain access to an international repository of data designed to aid industry and academic researchers developing new technologies to improve cardiac safety.

23 Sep 2010

Boston announces TAXUS ATLAS clinical trial data for complex lesions

Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.

23 Sep 2010

Biomatrica launches DNAgard Blood and DNAstable Blood sample stabilization products

Biomatrica Inc., the leader in room temperature biological sample stabilization, today announced the release of DNAgard® Blood and DNAstable® Blood.

22 Sep 2010

GATC Biotech to purchase PacBio real-time sequencing technology

GATC Biotech announced today that it has agreed to purchase the PacBio RS platform, a single molecule, real-time (SMRT™) sequencing technology. The new PacBio RS will be the fifth sequencing technology for GATC Biotech. The system is planned for installation in early 2011.

22 Sep 2010

MDI and Integrated Sciences enter exclusive distribution agreement for Detect-Ready MRSA assay in Australia

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in Australia.

22 Sep 2010

Nationwide Health Information Network tool to convey public health information

One hundred and sixty-six years after Samuel Morse used dots and dashes to telegraph "What hath God wrought?" opening up a whole new world of communication, Indiana has become the first state in the nation to use a potentially equally revolutionary tool, the Nationwide Health Information Network, to convey public health information to the U.S. Centers for Disease Control and Prevention.

22 Sep 2010

NIDA awards GeneGo SBIR grant to develop integrated systems biology platform for nicotine addiction research

GeneGo, Inc., the leading systems biology company, today announced that it has been awarded a grant from the National Institute on Drug Abuse to develop an integrated systems biology platform for research into the causes and treatment of tobacco dependence, nicotine addiction, smoking cessation and tobacco/nicotine withdrawal.

22 Sep 2010

AMS reports 12-month study results of Elevate Apical and Posterior Prolapse Repair System

American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the results of a 12-month single-arm, prospective multi-center study of the Elevate® Apical and Posterior Prolapse Repair System. The pelvic organ prolapse quantification exam (POP-Q), used to quantify, describe, and stage pelvic support, was implemented in the study and concluded efficacy rates of Stage 1 or less to be 89.2% for Apical and 91.7% for Posterior.

22 Sep 2010

Viking Systems to demonstrate 3DHD Visualization System at Sony's media event

Viking Systems, Inc. announced today its Next Generation 3DHD Visualization System for use in minimally invasive surgery will be prominently featured at Sony's media event to be held September 23, 2010 at Sony's offices in New York, NY. Jed Kennedy, Viking Systems President and CEO and Gerald Andriole, M.D., Medical Advisor to Viking Systems will address the media and explain the features and benefits of the system.

22 Sep 2010

Study finds certain MRI sequences as accurate methods of assessing stent stenosis

Researchers have found that magnetic resonance imaging (MRI) may be sufficient for the routine surveillance of some great vessel (primary blood vessels [e.g., aorta and vena cavae]) stents that are commonly used to treat congenital heart defects (a defect in the structure of the heart and great vessels that is present at birth) in children and young adults, according to a study in the October issue of the American Journal of Roentgenology (www.ajronline.org). MRI is a noninvasive medical test that helps physicians diagnose and treat medical conditions.

22 Sep 2010

Health insurer Highmark standardizes on Informatica Platform for enterprise-wide data integration

Informatica Corporation, the world's number one independent provider of data integration software, today announced that Highmark Inc., one of the largest health insurers in the United States, has standardized on the Informatica Platform for enterprise-wide data integration.

22 Sep 2010

ImThera Medical releases interim results of clinical study on neurostimulation device for treating OSA

ImThera Medical, Inc. today announced interim results from its OSA European clinical study. For the study, ten patients have been surgically implanted with ImThera's aura6000 hypoglossal nerve neurostimulation device for treating Obstructive Sleep Apnea. The target population for ImThera's neurostimulation device is moderate and severe OSA patients who are non-compliant with or cannot tolerate Continuous Positive Airway Pressure.

22 Sep 2010

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

St. Jude Medical, Inc., a global medical device company, today announced subset data results for the Angio-Seal™ Evolution™ Vascular Closure Device Registry. The results reaffirm the excellent sealing performance of the Angio-Seal Evolution vascular closure device in patients undergoing routine diagnostic and interventional cardiac catheterization procedures.

22 Sep 2010

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today announced the completion of patient follow-up in the Company's pivotal Phase III, Investigational Device Exemption (IDE) clinical trial with dermaPACE™ for the treatment of diabetic foot ulcers.

22 Sep 2010

Delphi Genetics licences StabyExpress technology for production of protein vaccines to GSK

Delphi Genetics SA has announced today the signature of a licensing agreement with GlaxoSmithKline for the use of the patented StabyExpress technology for the production of protein vaccines for human use.

22 Sep 2010

Agilent, ISB and ETH Zurich enter second phase of mapping complete human proteome

Ninth Annual World Conference of the Human Proteome Organization -- Agilent Technologies Inc. (NYSE:A) today announced that its collaboration with the Institute for Systems Biology (ISB) and the Swiss Federal Institute of Technology (ETH Zurich) for the mapping of the complete human proteome by mass spectrometry is entering its second phase.

22 Sep 2010

First in-human study of robotically assisted percutaneous coronary intervention system presented at 22nd TCT

The first in-human study of a robotically assisted percutaneous coronary intervention system demonstrated that the technique was safe and feasible. The results of the study were presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

22 Sep 2010

AACR to host fourth International Conference on Molecular Diagnostics

The American Association for Cancer Research will host its Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development from Sept. 27-30, 2010, at the Sheraton Denver Downtown in Denver, Colo.

22 Sep 2010

Gen-Probe submits PMA to FDA for PROGENSA PCA3 assay

Gen-Probe announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its PROGENSA® PCA3 assay, a new molecular test that may help determine the need for repeat biopsies in men suspected of having prostate cancer.

22 Sep 2010

Device / Technology News

BARDA awards Rapid Micro Biosystems $6.7M contract to develop rapid sterility testing platform for vaccines

AstraZeneca to use THEW database for cardiac safety evaluation

Boston announces TAXUS ATLAS clinical trial data for complex lesions

Biomatrica launches DNAgard Blood and DNAstable Blood sample stabilization products

GATC Biotech to purchase PacBio real-time sequencing technology

MDI and Integrated Sciences enter exclusive distribution agreement for Detect-Ready MRSA assay in Australia

Nationwide Health Information Network tool to convey public health information

NIDA awards GeneGo SBIR grant to develop integrated systems biology platform for nicotine addiction research

AMS reports 12-month study results of Elevate Apical and Posterior Prolapse Repair System

Viking Systems to demonstrate 3DHD Visualization System at Sony's media event

Study finds certain MRI sequences as accurate methods of assessing stent stenosis

Health insurer Highmark standardizes on Informatica Platform for enterprise-wide data integration

ImThera Medical releases interim results of clinical study on neurostimulation device for treating OSA

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

Delphi Genetics licences StabyExpress technology for production of protein vaccines to GSK

Agilent, ISB and ETH Zurich enter second phase of mapping complete human proteome

First in-human study of robotically assisted percutaneous coronary intervention system presented at 22nd TCT

AACR to host fourth International Conference on Molecular Diagnostics

Gen-Probe submits PMA to FDA for PROGENSA PCA3 assay

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News